Mouth device for severe obstructive sleep apnea after nerve stimulation did not work
Tests a jaw-advancing mouth device for severe sleep apnea in people unable to use CPAP.
Key facts
- Who runs it
- Washington University School of Medicine
- Where
- St Louis, United StatesSee the site
- Trial code
- Registry title
- Reducing Obstructive Sleep Apnea After Hypoglossal Nerve Stimulation Through Mandibular Advancement
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 29 Jul 2025
- Expected to end
- 1 Feb 2027
- Type of study
- Interventional
- Treatments tested
- Mandibular advancement device (MAD)
- Record updated
- 19 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with obstructive sleep apnea (breathing stops during sleep) whose hypoglossal nerve stimulation (HGNS) therapy did not work. They will test a mouth device that moves the lower jaw forward (MAD).
- Age
- 18 to 70 years
- Sex
- All sexes
- Disease stage
- Severe obstructive sleep apnea. People who cannot tolerate CPAP.
- Earlier treatment
- HGNS therapy must have failed: it was not tolerated, or it did not lower the AHI (breathing pauses per hour) enough by modified Sher criteria. People who could not tolerate a MAD before cannot join. No other sleep apnea treatment is allowed during the study.
Main reasons for not taking part
- Fewer than 9 healthy teeth per dental arch
- Chronic blocked nose
- Insomnia, narcolepsy, restless leg syndrome or other sleep disorders, or medicines for them
- Substance abuse or unstable psychiatric disorders
- Current GLP-1 receptor agonist use with ongoing weight loss, or a dose increase in the prior 8 weeks
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- Age ≥ 18 years
- Ability to read, write, speak, and understand English
- Failure of hypoglossal nerve stimulation (HGNS) therapy, defined as intolerance to HGNS or insufficient AHI reduction based on modified Sher criteria while using HGNS
- Ability to insert and remove the mandibular advancement device (MAD) independently
- Ability to complete all study assessments and evaluations, including home sleep apnea tests (HSAT)
- Ability to abstain from any other treatment for obstructive sleep apnea (OSA) during the entire study duration
- Access to an internet-connected device (phone, tablet, or laptop) with a camera
Who cannot take part
- Prior intolerance to MAD therapy
- Previous participation in a trial involving the use of oral appliances
- Dependence on or frequent use of medications that alter consciousness, respiration, or alertness
- Insomnia and/or use of medications to treat insomnia
- Current use of a GLP-1 receptor agonist (e.g., Zepbound, Wegovy, Ozempic, Mounjaro) with ongoing, active weight loss at the time of enrollment, or recent dose escalation within the prior 8 weeks
- Sleep disorders such as narcolepsy, insomnia, restless leg syndrome, or other disorders affecting sleep, and/or use of medications to treat such disorders
- Unstable psychiatric disorders
- Age over 70 years
- Inability to use a mandibular advancement device (MAD), defined as having fewer than 9 healthy teeth per dental arch
- Chronic nasal obstruction
- Substance abuse
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 70 years old?
Where in United States
- Washington University School of MedicineSt Louis, United StatesContact: Sara Kukuljan, BS, RNTaking people
About the trial
What the trial wants to find out
The purpose of this study is to evaluate the effectiveness, feasibility, and safety of mandibular advancement devices (MAD) for treating severe obstructive sleep apnea (OSA) in patients who are CPAP intolerant and have failed hypoglossal nerve stimulation (HGNS).
The group in the trial
- Mandibular Advancement Device (MAD)Treatment being tested
This study is experimental. It involves a single-intervention design where participants who have failed hypoglossal nerve stimulation (HGNS) therapy for moderate to severe obstructive sleep apnea (OSA) will be treated with a mandibular advancement device (MAD).
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Reducing Obstructive Sleep Apnea After Hypoglossal Nerve Stimulation Through
- Plain-language title
- Mouth device for severe obstructive sleep apnea after nerve stimulation did not workGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT07132307, who can take part
- Record updated
- 19 March 2026